Rondo Therapeutics Closes $67 Million Series A Financing to Advance Next-Generation Immuno-Oncology Platform for Solid Tumors

/PRNewswire/ -- Rondo Therapeutics, a biopharmaceutical company advancing a next-generation immuno-oncology platform for treating solid tumors, today announced...

Related Keywords

Jon Edwards ,Nils Lonberg ,Nina Kjellson ,Nathan Trinklein ,Sv Health Investors ,Shelley Force Aldred ,Jjdc Inc ,Novo Holdings ,Rondo Therapeutics ,Red Tree Venture Capital ,Canaan Partners ,Johnson Innovation ,Red Tree ,Force Aldred ,Strategic Partners ,